Celldex Therapeutics, Inc. is 1.2x more valuable than NEOGEN CORP by market capitalization ($2.35 B vs $2.01 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NEOG | CLDX |
|---|---|---|
| Market cap | $2.01 B | $2.35 B |
| US-listed rank | #2102 | #1990 |
| Revenue (latest FY) | $894.66M | $1.54M |
| Net income (latest FY) | -$1.09B | -$258.76M |
| Net margin | -122.1% | -16748.0% |
| SEC filings | 1,896 | 1,268 |
Celldex Therapeutics, Inc. is 1.2x more valuable than NEOGEN CORP by market capitalization ($2.35 B vs $2.01 B).
In their latest fiscal years, NEOGEN CORP reported $894.66M in revenue while Celldex Therapeutics, Inc. reported $1.54M.
Full pages: NEOGEN CORP and Celldex Therapeutics, Inc., or browse the full rankings.